Tests fetal tracheal occlusion for severe congenital diaphragmatic hernia in unborn babies
Tests a device that blocks the windpipe of unborn babies with severe diaphragmatic hernia.
Key facts
- Who runs it
- Children's Hospital Medical Center, Cincinnati
- Where
- Cincinnati, United StatesSee the site
- Trial code
- Registry title
- Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- Nov 2016
- Expected to end
- Dec 2026
- Type of study
- Interventional
- Treatments tested
- Fetal Tracheal Occlusion
- Record updated
- 11 May 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women, 18 to 50 years old, carrying one baby with severe or moderate congenital diaphragmatic hernia (CDH), a hole in the diaphragm. The trial tests a balloon placed in the baby's windpipe to help the lungs grow.
- Age
- 18 Years to 50 Years
- Sex
- Female
- Disease stage
- Baby has CDH on its own, with the liver up in the chest. Severe: ultrasound O/E LHR <25%, procedure at 27 weeks 0 days to 29 weeks 6 days. Moderate: O/E LHR <30%, procedure at 30 weeks 0 days to 31 weeks 6 days.
- Earlier treatment
- The family has considered and declined ending the pregnancy before 24 weeks 0 days. No other prior treatment is named.
- Biomarker or test result
- The baby's chromosome test (karyotype or FISH) and heart ultrasound must be normal.
Main reasons for not taking part
- Twins or more babies
- Other abnormalities in the baby, or chromosome problems
- Preterm labor, short cervix (<15 mm), weak cervix, placenta previa or placenta problems
- Rubber latex allergy
- Mother with HIV, Hepatitis B or Hepatitis C
This trial only enrols pregnant participants. The registry sentence this rests on: Singleton pregnancy
The registry criteria, word for word
Show all 27 criteriaShow less
Who can take part
- Isolated CDH with liver up
- Severe pulmonary hypoplasia with ultrasound O/E LHR <25% at the time of surgery
- Gestational age at FETO procedure 27 weeks 0 days to 29 weeks 6 days
- Moderate pulmonary hypoplasia with ultrasound O/E LHR <30% and liver-up at the time of surgery
- Gestational age at FETO procedure 30 weeks 0 days to 31 weeks 6 days in this moderate category
- Maternal age greater than or equal to 18 years
- Gestational age at enrollment prior to 29 weeks 6 days, or 31 weeks 6 days in moderate category
- Normal karyotype or FISH
- Normal fetal echocardiogram
- Singleton pregnancy
- Willing to remain in the greater Cincinnati area for remainder of pregnancy
- Family considered and decline option of termination of the pregnancy at less than 24 weeks 0 days
- Family meets psychosocial criteria
Who cannot take part
- Participation in another intervention study that influences maternal and fetal morbidity and mortality or participation in this trial in a previous pregnancy
- Rubber latex allergy
- Maternal contraindications to fetoscopic surgery or severe maternal condition in pregnancy
- Maternal HIV, Hepatits B, Hepatitis C
- Patient < 18 years old
- Multi-fetal pregnancy
- Preterm labor, cervix shortened (<15 mm) or uterine anomaly strongly predisposing to preterm labor, placenta previa
- Bilateral CDH, isolated left sided CDH with an O/E > 30%
- Additional fetal anomaly by ultrasound, MRI, or echocardiogram
- Chromosomal abnormalities
- Incompetent cervix with or without a cerclage
- Placental abnormalities known at time of enrollment
- Maternal uterine anomaly
- No safe or technically feasible fetoscopic approach to balloon placement
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
This trial is currently available in United States.
- Cincinnati Children's Hospital Medical Center (CCHMC)Cincinnati, United StatesContact: Foong-Yen Lim, MDTaking people
About the trial
What the trial wants to find out
Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses.
The group in the trial
- Fetal Tracheal OcclusionTreatment being tested
Fetuses with severe or moderate congenital diaphragmatic hernia will be offered fetal tracheal occlusion to increase lung growth.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia
- Plain-language title
- Tests fetal tracheal occlusion for severe congenital diaphragmatic hernia in unborn babiesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Criteria questions
- Built from NCT02986087, who can take part
- Record updated
- 11 May 2025